In a recent systematic review, results from 20 TNF- inhibitor de-escalation studies (14 RCTs and six non-RCTS) determining the actual reduction in the occurrence of adverse events when de-escalating the existing therapy in different inflammatory conditions, such as psoriasis, axSpA, RA, and IBD, were summarized
Moreover, GLP-1 analogues cause a reduction in cardiovascular events in non-diabetic individuals [17]
The further into the fasted period you administer, the longer the window of enhanced fat oxidation before food intake raises insulin
Peptide allergies While rare, its possible to become allergic to peptide coupling agents (a necessary part of synthetic peptide manufacturing).18 19 This risk is much higher in researchers who frequently handle or are exposed to these compounds
Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y